Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetylcysteine for prevention of remdesivir-associated liver injury in ICU patients with COVID-19
IRCT20210726051995N1Phase 3Completed
- Sponsor
- Aja University of Medical Sciences
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in coronavirus pneumonia comparing Acetylcysteine + remdesivir with Placebo + remdesivir (2 arms). Primary endpoints: Aspartate aminotransferase, Alanine aminotransferase and 3 more. Started Jul 2021; status: completed.
02
Drugs
acetylcysteine
03
Conditions
coronavirus pneumonia
Beyond the preview
Go deeper on IRCT20210726051995N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210726051995N1.